Scheda del titolo
VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
46Holder monitorati
+15Δ titolari
17.25MQuote detenute
$317.51MValore dichiarato
+16Nuove posizioni
−1Uscite
Input di momentum (manager comparabili):
ampiezza dei detentori +30.0% ·
flusso azionario +30.0% ·
nuove posizioni nette +20.0%
— formula
Accumulo diffuso — azioni in aumento tra un maggior numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q2 2026
Proprietà nel tempo
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | — | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | — | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | — | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | — | — |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | — | 1.49M | $1.49M | — | — |
Chi lo detiene · Q2 2026
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.93M | +220.3% | $90.80M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (passivo) | 3.47M | +336.4% | $63.85M | 0.0% | ▲ Add | 5 | SEC ↗ ×9 |
| 3 | State Street Global Advisors ✦ (passivo) | 2.62M | +133.9% | $48.17M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 4 | Vanguard Capital Management Llc | 2.08M | +45.4% | $38.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passivo) | 1.06M | +210.1% | $19.56M | 0.0% | ▲ Add | 9 | SEC ↗ ×2 |
| 6 | UBS Group AG | 493.28K | +1.0% | $9.08M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 428.07K | +65.5% | $7.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 328.89K | +25.6% | $6.05M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | Northern Trust Corp | 328.74K | +409.3% | $6.05M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Bank Of America Corp /De/ | 177.74K | +57.4% | $3.27M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 160.41K | +7.8% | $2.95M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Charles Schwab Investment… | 121.40K | +446.4% | $2.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Bank of New York Mellon Corp | 97.72K | Nuovo | $1.80M | 0.0% | New | 1 | SEC ↗ ×3 |
| 14 | Marshall Wace ✦ | 95.64K | -91.7% | $1.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Nuveen, LLC | 94.81K | Nuovo | $1.75M | 0.0% | New | 1 | SEC ↗ ×2 |
| 16 | Invesco Ltd. | 68.30K | +488.8% | $1.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Citigroup Inc | 63.13K | +1075.0% | $1.16M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 18 | Morgan Stanley ✦ | 61.56K | -47.3% | $1.13M | 0.0% | ▼ Trim | 4 | SEC ↗ ×6 |
| 19 | Rhumbline Advisers | 57.53K | Nuovo | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 54.67K | Nuovo | $1.01M | 0.0% | New | 1 | SEC ↗ ×2 |
| 21 | T. Rowe Price ✦ | 41.81K | Nuovo | $770,000 | 0.0% | New | 1 | SEC ↗ |
| 22 | Deutsche Bank Ag\ | 40.35K | Nuovo | $742,862 | 0.0% | New | 1 | SEC ↗ ×2 |
| 23 | Alliancebernstein L.P. | 37.21K | Nuovo | $685,036 | 0.0% | New | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 37.01K | Nuovo | $681,391 | 0.0% | New | 1 | SEC ↗ |
| 25 | Wells Fargo & Company/Mn | 36.27K | +3627200.0% | $667,786 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 33.01K | -74.4% | $607,733 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 27.10K | Nuovo | $498,911 | 0.0% | New | 1 | SEC ↗ ×2 |
| 28 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 24.38K | +594.0% | $449,932 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 29 | Squarepoint Ops LLC | 23.23K | -8.8% | $427,683 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | Sei Investments Co | 23.02K | +67.8% | $423,855 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 31 | JPMorgan Chase ✦ | 21.62K | +395.4% | $402,150 | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 32 | Tudor Investment Corp Et Al | 19.62K | -87.1% | $361,204 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 33 | Susquehanna International Group, Llp | 16.45K | -92.9% | $302,918 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 34 | Barclays Plc | 14.56K | +10609.6% | $268,142 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 35 | New York State Common Retirement… | 14.30K | Nuovo | $263,263 | 0.0% | New | 1 | SEC ↗ |
| 36 | Manufacturers Life Insurance… | 10.79K | Nuovo | $198,699 | 0.0% | New | 1 | SEC ↗ |
| 37 | Bnp Paribas Financial Markets | 10.71K | +276.5% | $197,134 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | Legal & General Group Plc | 8.01K | Nuovo | $147,482 | 0.0% | New | 1 | SEC ↗ ×2 |
| 39 | Russell Investments Group, Ltd. | 3.26K | Nuovo | $59,942 | 0.0% | New | 1 | SEC ↗ |
| 40 | Group One Trading Llc | 2.96K | -67.3% | $54,549 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 41 | Mirae Asset Global Investments Co.… | 2.42K | +11.9% | $44,607 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | Royal Bank Of Canada | 1.26K | +533.2% | $23,000 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 43 | Pacer Advisors, Inc. | 815 | Nuovo | $15,000 | 0.0% | New | 1 | SEC ↗ |
| 44 | Pnc Financial Services Group, Inc. | 308 | +25.2% | $5,670 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 45 | Northwestern Mutual Wealth… | 180 | Nuovo | $3,314 | 0.0% | New | 1 | SEC ↗ |
| 46 | Osaic Holdings, Inc. | 2 | Nuovo | $37 | 0.0% | New | 1 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Bank of New York Mellon Corp | $1.80M | 0.0% |
| Nuveen, LLC | $1.75M | 0.0% |
| Rhumbline Advisers | $1.06M | 0.0% |
| D. E. Shaw & Co. | $1.01M | 0.0% |
| T. Rowe Price | $770,000 | 0.0% |
| Deutsche Bank Ag\ | $742,862 | 0.0% |
| Alliancebernstein L.P. | $685,036 | 0.0% |
| Two Sigma Investments | $681,391 | 0.0% |
| Wellington Management | $498,911 | 0.0% |
| New York State Common… | $263,263 | 0.0% |
| Manufacturers Life Insurance… | $198,699 | 0.0% |
| Legal & General Group Plc | $147,482 | 0.0% |
Uscito
| Jane Street Group, Llc | $1.35M | era 0.0% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 79 detentori, 40.44M azioni, $716.36M dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Frequentemente co-detenuti
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Aug 14
SC 13G/A — Venrock Healthcare Capital Partners…
Aug 14
SC 13G/A — Frazier Life Sciences Public Fund, L.P.
Aug 13
SC 13G/A — Verve Capital Ltd
Aug 07
SC 13G/A — FMR LLC
Aug 06
SC 13G — FMR LLC
Jul 30
SC 13G — BlackRock, Inc.
Jul 21
SC 13D/A — RA CAPITAL MANAGEMENT, L.P.
19.9% di classe · Visualizza la dichiarazione SEC originale ↗
Provenienza: Proprietà ricavata dalle posizioni in azioni ordinarie 13F analizzate (universo monitorato, set comparabili per le variazioni); righe insider dai Moduli 3/4/5; partecipazioni dagli Schedule 13D/13G; ogni filing rimanda all'originale su SEC EDGAR.
Periodo di rendicontazione: Q2 2026 ·
Metodologia ·
Ottieni questo tramite l'API